Fiserv
FISV · NASDAQ
About FISV
- Employees
- 38,000
- Headquarters
- Milwaukee, Wisconsin
- Listed
- Sep 25, 1986
- Sector
- Financials
- Industry
- Financial Services
- Website
- fiserv.com
FISV key statistics
- Market cap
- 25.36B
- Price-earnings ratio
- 9.15
- Dividend yield
- —
- Average volume
- 6.08M
- Volume
- 2.34M
- Open price
- $47.86
- High today
- $48.37
- Low today
- $47.82
- 52 Week high
- $128.78
- 52 Week low
- $43.87
Fiserv (FISV) at a glance
As of Oct 20, 2026, Fiserv (FISV) shares are priced at $48.25, giving the company a market cap of 25.36B and a price-to-earnings ratio of 9.15.
Today the stock has traded between $47.82 and $48.37. The current price is 0.9% above the day's low and 0.2% below its high.
Volume so far is 2.34M shares, below the average of 6.08M shares a day.
Over the past year Fiserv has ranged from $43.87 to $128.78, and now sits 5% of the way up that range.
Fiserv met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q2 FY26 it reported $1.84 per share against an estimate of $1.95.
The average analyst price target is $63.91, 32.5% above the current price, from 23 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy21.7%
- Hold73.9%
- Sell4.3%
- Low
- $40.40
- Now
- $48.25
- High
- $110.37
FISV earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 3 of the last 8 quarters, by 5.2% on average.
- Q3 FY24: reported $2.30 per share against an estimate of $2.31
- Q4 FY24: reported $2.51 per share against an estimate of $2.53
- Q1 FY25: reported $2.14 per share against an estimate of $2.12
- Q2 FY25: reported $2.47 per share against an estimate of $2.48
- Q3 FY25: reported $2.04 per share against an estimate of $2.70
- Q4 FY25: reported $1.99 per share against an estimate of $1.93
- Q1 FY26: reported $1.79 per share against an estimate of $1.60
- Q2 FY26: reported $1.84 per share against an estimate of $1.95
FISV news
- Press releasePRNewswire
- Press releaseBusiness Wire
Klarna Expands Fiserv Partnership to Enterprise Merchants After Going Live at 100,000 U.S. Locations via Clover
- Press releaseGlobe Newswire
Fiserv Simplifies Cross-Border Commerce with Commerce Hub™
- Press releaseGlobe Newswire
Fiserv Surpasses 5 Million Clover Devices Shipped Worldwide
- Press releasePRNewswire
FULTON BANK INTRODUCES CASHFLOW CENTRAL PLATFORM TO EMPOWER SMALL BUSINESSES
- Press releaseGlobe Newswire
Hard Rock Stadium Selects Clover Sport to Power Point-of-Sale Solutions
- Press releaseGlobe Newswire
Fiserv to Release Third Quarter Earnings Results on November 3, 2026
Fiserv Q2 2026 Earnings Call Transcript
Similar companies
Companies in the same industry as Fiserv
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.